Anbio Biotechnology (NNNN) stock
Close on Nov 13, 2026Market cap $549.66MP/E 26.0Yield –
Anbio Biotechnology statistics
80 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2025
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 18.23
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 62.19
- 2.57
- EV / EBIT
- 93.24
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- 3.27%
- 10.8%
- Float
- 144M
- 49M
- Shares Held by Insiders
- 0.00%
- 11.7%
Short sellingIndustry
- Short Interest
- 33,299
- –
- Short Interest Change
- 6.99%
- -0.80%
- Short % of Float
- 0.02%
- 9.01%
- Short % of Shares Outstanding
- 0.02%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $44.73
- –
- 52-Week Low
- $3.09
- –
- 20-Day Moving Average
- $3.72
- –
- 50-Day Moving Average
- $4.75
- –
- 200-Day Moving Average
- $16.12
- –
- Average True Range (14)
- $0.45
- –
- Price Change (1 Week)
- -1.80%
- -1.15%
- Price Change (1 Month)
- 15.8%
- -4.87%
- Price Change (3 Months)
- -55.0%
- -21.0%
- Price Change (6 Months)
- -85.8%
- -20.6%
- Price Change (YTD)
- -87.3%
- -23.6%
- Price Change (1 Year)
- -83.0%
- -22.4%
- Average Volume (10 Days)
- 38,756
- –
- Average Volume (20 Days)
- 51,211
- –
- Average Volume (90 Days)
- 118,985
- –
- Relative Volume
- 0.18
- 0.70
- Relative Strength Index (14)
- 44.0
- 43.4
- Volatility (1 Year)
- 114.4%
- 80.1%
MarginsIndustry
- Pretax Margin
- 74.1%
- -11.6%
- EBITDA Margin
- 66.7%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- 27.0%
- -49.9%
- Return on Assets (ROA)
- 26.0%
- -40.6%
- Return on Invested Capital (ROIC)
- 48.7%
- -32.9%
- Return on Capital Employed (ROCE)
- 19.1%
- -37.9%
Financial positionIndustry
- Current Ratio
- 344.31
- 3.30
- Quick Ratio
- 177.12
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 5.64%
- 6.82%
- Net Income Growth (YoY)
- 169.9%
- -14.4%
- EPS Growth (YoY)
- 162.5%
- -12.3%
- Revenue Growth (3Y CAGR)
- -28.4%
- 2.25%
- EPS Growth (3Y CAGR)
- -98.9%
- 1.30%
EfficiencyIndustry
- Asset Turnover
- 0.35
- 0.40
- Revenue Per Employee
- $320.25K
- $429.29K
- Profits Per Employee
- $237.17K
- -$689.41K
- Employee Count
- 27
- 74
Income statement (TTM)Industry
- Pretax Income
- $6.40M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $11.90M
- $17.76M
- Net Cash Per Share
- $0.08
- $0.80
- Equity (Book Value)
- $30.16M
- $53.89M
- Book Value Per Share
- $0.21
- $1.50
- Tangible Book Value
- $30.16M
- $27.13M
- Working Capital
- $30.16M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 1.16%
- -21.8%
- Buyback Yield
- -1.32%
- -0.76%
- Shareholder Yield
- -1.32%
- 0.00%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
- Effective Tax Rate
- 0.00%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $0.83
- $19.34
- Graham Upside
- -78.2%
- -46.6%
- Altman Z-Score
- 3757.91
- 0.23
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NNNN | S&P 500 | Difference | NNNN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.3% | -3.0% | −7.3 pts | ||
| 3 months | -62.8% | -2.8% | −60.0 pts | ||
| Year to date | -87.3% | +11.5% | −98.8 pts | ||
| 1 year | -83.6% | +13.5% | −97.1 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M NNNN shares were sold short on Oct 30, 2026, up 7.0% from the previous report, or 0.02% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 50.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 33,299 | +7.0% | 60,972 | 1.0 |
| Oct 15, 2026 | 31,124 | -42.4% | 46,624 | 1.0 |
| Sep 30, 2026 | 54,022 | +4.5% | 204,550 | 1.0 |
| Sep 15, 2026 | 51,672 | -11.6% | 255,861 | 1.0 |
| Aug 31, 2026 | 58,423 | +122.9% | 286,803 | 1.0 |
| Aug 14, 2026 | 26,210 | -44.9% | 49,980 | 1.0 |
| Jul 31, 2026 | 47,525 | +50.5% | 38,778 | 1.2 |
| Jul 15, 2026 | 31,583 | -64.6% | 42,616 | 1.0 |
| Jun 30, 2026 | 89,295 | +0.8% | 63,728 | 1.4 |
| Jun 15, 2026 | 88,550 | +1.3% | 35,905 | 2.5 |
| May 29, 2026 | 87,425 | -5.6% | 22,340 | 3.9 |
| May 15, 2026 | 92,563 | +111.7% | 22,120 | 4.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?